Clinical Trials
4 trialsNCT02470091 2024-01-22
Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma
Children's Oncology Group
Phase 2 Completed
NCT01345019 2022-11-08
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma
Amgen
Phase 3 Completed
NCT04798326 2021-03-15
MW032
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 1 Completed
NCT02996734 2016-12-22
GCTLIMBS
Istituto Ortopedico Rizzoli
Completed